MedTrace Logo

Facilitating Communication Study

NCT03721952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 977

Last updated 2025-02-07

Study results available
· View outcomes & findings →

Summary

This study is a randomized clinical trial of an intervention to improve outcomes for patients and their family by using ICU nurse facilitators to support, model, and teach communication strategies that enable patients and their families to secure care in line with patients' goals of care over an illness trajectory, beginning in the ICU and continuing to care in the community.

Conditions

  • Chronic Disease
  • Neoplasm Metastasis
  • Lung Neoplasm
  • Pulmonary Disease, Chronic Obstructive
  • Heart Failure, Congestive
  • Liver Cirrhosis
  • Kidney Failure, Chronic
  • Multiple Organ Failure
  • Health Care Quality, Access, and Evaluation
  • Intensive Care Units
  • Palliative Care, Health Services
  • Palliative Care, Patient Care
  • Lung Diseases
  • Cerebrovascular Disorders
  • Brain Injuries

Interventions

BEHAVIORAL

Facilitator-Based Intervention

Facilitators interact in person or by telephone with patients, family, and clinicians both during and following the patient's ICU stay for 3 months. In-person contacts include visits to patients' homes and/or care facilities; phone contacts include calls to patients, families and clinicians. Patients and families have access to facilitators through phone and email 5 days per week. Facilitators may attend clinic visits with patients. In addition to checking directly with patients/families during regular contacts, facilitators also access the electronic health record to ensure they have accurate information about appointments and treatment plans and to document key points for the clinical team. Facilitators encourage referral to inpatient or outpatient palliative care services when needs are identified.

Sponsors & Collaborators

Principal Investigators

  • Ruth A Engelberg, PhD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2023-10-26
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721952 on ClinicalTrials.gov